Based on record review and interview, the facility failed to ensure anticoagulant medication was not administered without adequate monitoring for 2 (#1 and #2) of 5 sampled residents reviewed for unnecessary medication.MDS Coordinator #1 identified 15 residents received anticoagulant (blood thinner) medication resided in the facility. Findings: 1. A physician's order for Resident #1, dated 09/16/24, for Xarelto (anticoagulant medication) 15 mg one tablet by mouth one time a day related to atrial fibrillation. There was no order for monitoring side effects of the anticoagulant medication. An annual assessment Resident #1, dated 03/20/26, showed the resident had diagnoses which included coronary artery disease, atrial fibrillation, and heart failure. …
F757 citations in Oklahoma
Unnecessary drugs · Pharmacy Service Deficiencies
Ensure each resident’s drug regimen must be free from unnecessary drugs.
Data as of , released by CMS on October 8, 2026. Source: CMS Provider Data Catalog.
Against expectation — 2025
Oklahoma cites F757 more often than its own record predicts
1.11 times the share F757 takes of citations nationally.
Of every deficiency written in Oklahoma in 2025, this is the portion that was F757.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What Oklahoma surveyors wrote
F757 findings written in Oklahoma, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
The short window
Recent years
| Year | Share of Oklahoma citations | vs expected |
|---|---|---|
| 2023 | 0.96% | 1.19× |
| 2024 | 0.69% | 0.99× |
| 2025 | 0.88% | 1.11× |
Shares of citations, not counts: earlier years hold fewer inspections.
What else Oklahoma surveyors cite →
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction